Navigation Links
PETLinQ to Debut Pure Web Based PET/CT Fusion Viewer at June 2009 SNM Conference
Date:5/12/2009

New Thin Client PET/CT Viewer to Provide High Quality Viewing Capability on a Flexible yet Affordable Web Based Platform

Washington, D.C. (PRWEB) -- PETLinQ LLC, a leading radiology solutions provider, is proud to announce the release of its newest product innovation - SoftStationWeb - a pure thin client web based application created for the viewing of full PET/CT data sets with fused images, requiring only a secure password and login; no downloading of any kind is needed.

Harsha Hatti, PETLinQ’s President and CEO explains, “The need to provide fresh and innovative portable technologies is absolutely critical in driving the much needed efficiencies and access to real time information within healthcare today. PETLinQ intends to lead in this space by providing fresh and new solutions that deliver these efficiencies and access while effectively connecting the key stakeholders in radiology – the radiologist, the referring physician, the facility and the patient. “

SoftStationWeb offers a host of features that cater to the needs of these stakeholders. Referring physicians can have access to key reports and view full PET/CT studies via SoftStationWeb through their own referring physician portal. The referring physicians will have access to all the relevant tools, SUV/HU, axial, sagital, coronal data, triangulation, zooming, fusion blend and many other tools at their fingertips without the need to download cumbersome large data sets or client side software. With the use of this new technology, the need for burning

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. PetlinQ Signs Agreement With SpeakLike for Accurate, Real-Time Translation Chat
2. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
3. Virgin America Airline Debuts With MedAire Services
4. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
5. American Heart Association Announces Debut of Health Management Tool on Microsoft HealthVault
6. Corporate Fitness Show to Debut in Chicago October 10-13
7. Mirixa Debuts RxFYI - a Free Pharmacy-Published Health eNewsletter Building Patient Loyalty and Generating Revenue
8. Health Insurance Finders Debuts A Comprehensive Guide to Family Health Insurance
9. Rutgers biomaterial debuts in clinical trials of new stent
10. Long Term Care Newsletter Debuts, Published by LTC Financial Partners; Advice on Living Better, Not Just Longer, With Financial Protection
11. Sneaky Chefs Recipes Make Delicious Debut at Morgan Stanley Childrens Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PETLinQ to Debut Pure Web Based PET/CT Fusion Viewer at June 2009 SNM Conference
(Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... and NEW HAVEN, Conn., Jan. 14 ... RHEI Pharmaceuticals,Inc. ("RHEI"), a specialty pharmaceutical company ... market, today announced the signing of a,definitive ... more than 110,national sales representatives penetrating large ...
... in Medical Products, Specialty Coatings, ... Transportation and Print Solutions, DETROIT, Jan. ... quarter of 2007 the firm added five companies to its,portfolio, ... completed 14,acquisition and divestiture transactions valued at over $225 million. ...
... ChemoOrders.com Improves the Way Doctors and Nurses Prescribe Chemotherapy ... ... Georgia Cancer Specialists (GCS) wants,to change the way oncology professionals ... and nurses,administer current chemotherapy protocols in a more accurate and efficient,manner. ...
... , , MONDAY, Jan. 14 (HealthDay News) -- Tysabri, a controversial ... for patients with a moderate to severe form of another ... announced Monday. , But the drug also comes with a ... as well as other side effects, so it must be ...
... green glow from a fruit fly is giving researchers the ... their quest to develop compounds that help prevent cancer. , ... workhorse of the genetics world, lets researchers know when powerful ... broccoli, cabbage, and other foods, have been turned on in ...
... Edwards Lifesciences,Corporation (NYSE: EW ), a world ... disease, announced today that it has,completed the sale ... line to C.R. Bard, consistent with the terms ... Lifesciences, a leader in advanced cardiovascular disease,treatments, is ...
Cached Medicine News:Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 2Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 3Health News:Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 2Health News:Huron Capital Caps Strong Year With Five Acquisitions In 4Q07 3Health News:Local Oncology Group Leads Online Effort to Revolutionize Cancer Care 2Health News:MS Drug Tysabri Approved for Crohn's Disease 2Health News:MS Drug Tysabri Approved for Crohn's Disease 3Health News:Fruit flies all aglow light the way to cancer prevention 2Health News:Fruit flies all aglow light the way to cancer prevention 3
(Date:1/22/2015)...  Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... to treat voiding dysfunctions, today reported financial results for ... Global revenue for the Company,s Urgent ®  PC ... quarterly revenue record, as compared to $3.9 million in ...
(Date:1/22/2015)... 22, 2015  Amgen (NASDAQ: AMGN ) today announced that ... results on Tuesday, Jan. 27, 2015, after the close of the ... call with the investment community at 2 p.m. PT. Participating in ... chairman and chief executive officer, and other members of Amgen,s senior ...
(Date:1/22/2015)... , Jan. 22, 2015 Increasing sophistication among enterprise ... of localization purchasing in 2015, says Moravia ... a recent study by market research firm Common Sense ... solution for their translation and localization needs. "From a ...
Breaking Medicine Technology:Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... on Glucose Homeostasis Effects in,Normal and Diabetic Rats ... a 14-day,Phase IIa study of the safety profile ... selective inhibitor of,the Sodium-Glucose Transporter 2 (SGLT2) administered ... 2 diabetes, no,discontinuations due to adverse events and ...
... LOUISVILLE, Colo., June 26, 2007 /PRNewswire-FirstCall/ --,Replidyne, ... I trials,studying REP8839, a novel topical antibiotic ... major skin pathogens including,methicillin-resistant S. aureus (MRSA). ... that topically applied REP8839 appears safe,well-tolerated and ...
Cached Medicine Technology:First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
... intended for monitoring the accuracy and precision of ... in vitro diagnostic use only. Provided in a ... up to ten days stability at 2 ... used in accordance with the directions accompanying the ...
PowerMed is a billing software....
Managed care is a billing and tracking system....
Medicine Products: